United Therapeutics buy Royal Bank of Canada
Start price
26.09.25
/
50%
€364.40
Target price
26.09.26
€487.63
Performance (%)
33.73%
Price
10.04.26
€487.30
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for United Therapeutics has seen massive gains of 33.73%. This prediction currently runs until 26.09.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -0.429% | -0.429% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $569.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
14.15%
10.04.26
10.04.26
